Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Ketamine

There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics…
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl…
Expanding Horizons $20.677M Market Capitalization Optimi Health Corp. (OPTI.C) announced today that it has entered into a supply agreement with SABI Mind. According to the terms of the agreement,…
Algernon Pharmaceuticals (AGN.C) filed a combined clinical trials of investigational medicinal products and ethics approval application with the United Kingdom Medicines and Healthcare Products Regulatory Agency for its planned…
The world’s first psychedelic ETF, PSYK, is an industry bellwether which indicates the psychedelics space continues to take a drubbing since the ETF launched in January.  The fund closed…
Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
Awakn Life Sciences (AWKN.NE) announced it has received ethical approval to conduct the first-ever study of the effects of ketamine on gambling addiction. Awakn has begun to recruit patients…
Core One Labs’ (COOL.C) wholly-owned subsidiary Akome Biotech announced they are initiating the next step of their clinical development of their patent-pending psychedelic formulations AKO001 and AKO003. The next…
PharmaTher (PHRM.C) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS), also…